Cargando…
Progress and challenges in the vaccine-based treatment of head and neck cancers
Head and neck (HN) cancer represents one of the most challenging diseases because the mortality remains high despite advances in early diagnosis and treatment. Although vaccine-based approaches for the treatment of advanced squamous cell carcinoma of the head and neck have achieved limited clinical...
Autor principal: | Venuti, Aldo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695420/ https://www.ncbi.nlm.nih.gov/pubmed/19473517 http://dx.doi.org/10.1186/1756-9966-28-69 |
Ejemplares similares
-
Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021) -
Oligometastatic Head and Neck Cancer: Challenges and Perspectives
por: Bahig, Houda, et al.
Publicado: (2022) -
Personalized cancer vaccination in head and neck cancer
por: Shibata, Hirofumi, et al.
Publicado: (2021) -
A review on the advances and challenges of immunotherapy for head and neck cancer
por: Cheng, Gang, et al.
Publicado: (2021) -
Research progress of radiation-induced hypothyroidism in head and neck cancer
por: Zhou, Ling, et al.
Publicado: (2021)